According to the Implementation Plan, newly diagnosed HIV infection, drug resistance monitoring, and CD4+ T cell detection should be combined, so that key populations and areas with newly diagnosed HIV infection could be accurately identified, and effectively targeted preventive measures could be taken. This evidence concerns the gene CD4 and HIV infectious disease.